Friday, July 10, 2026

Drug profile · INN

riboflavin 5'-phosphate

riboflavin 5'-phosphate (PHOTREXA VISCOUS IN DEXTRAN 20%) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — riboflavin 5'-phosphate
US status
approved
Class
Route
OPHTHALMIC
Patents
0
Programs
1
Data quality
0.84

Quick answer

riboflavin 5'-phosphate (PHOTREXA VISCOUS IN DEXTRAN 20%) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.

Key facts

INN riboflavin 5'-phosphate
Brand PHOTREXA VISCOUS IN DEXTRAN 20%
Route OPHTHALMIC
Formulation SOLUTION/DROPS

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. Riboflavin Phase 2 · United Therapeutics Europe · Keratolysis

Frequently asked questions

What is riboflavin 5'-phosphate?

riboflavin 5'-phosphate (PHOTREXA VISCOUS IN DEXTRAN 20%) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.

What is the brand name for riboflavin 5'-phosphate?

PHOTREXA VISCOUS IN DEXTRAN 20% is a marketed brand name for riboflavin 5'-phosphate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of riboflavin 5'-phosphate?

riboflavin 5'-phosphate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.